Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Health Care Higher This Week, This Co. is Behind New Tech that Fights the Flu

Stockhouse Editorial
2 Comments| August 27, 2021

{{labelSign}}  Favorites
{{errorMessage}}

Click to enlarge
Medigus Ltd. (NASDAQ: MDGS, Forum) stock has climbed 10.1% over the week.

The company capped it off with news that a private company that it owns a significant stake in had presented pre-clinical data that showed its distinct platform technology has the potential to reduce the risk of an infection with Influenza virus H1N1 and could also potentially treat additional cold viruses.

That company is Polyrizon Ltd., of which Medigus owns a 35.86% of its share capital.

The Health Care seed-stage company develops novel biological-gels and in a media release for investors on Friday, Medigus stated that the data that Polyrizon shared from its cell-culture study confirmed that its innovative product works in a dose-dependent manner to effectively reduce the infection of cells from the influenza virus H1N1.

Polyrizon’s new product candidate protects the nasal cavity and the respiratory tract. In its H1N1 studies, product candidates demonstrated high efficacy by preventing the influenza virus from affecting epithelial host cells and inhibit cells death.

It was also pointed out that use of the Capture and Contain platform technology would help provide a boost in Polyrizon’s product line extended against flu and cold viruses along with a variety of different respiratory viruses.

Medigus is a technology company that works with advanced medical solutions, innovative internet technologies, and electric vehicle and charging solutions. It acquired a private company earlier this month that produces branded products sold at stores like Walmart, Target, Staples, Kroger, and others.

For more details on the company, visit medigus.com.


FULL DISCLOSURE: Medigus Ltd. Is a client of Stockhouse Publishing.


{{labelSign}}  Favorites
{{errorMessage}}

Comments

No comments yet. Be first to comment!

Leave a Comment

You must be logged in to be able to post a comment.

Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today